SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

ZAULI, Giorgio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.695
AS - Asia 15.502
EU - Europa 9.367
SA - Sud America 2.582
AF - Africa 347
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 58.541
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.077
SG - Singapore 5.917
CN - Cina 3.737
IT - Italia 2.627
BR - Brasile 2.047
VN - Vietnam 1.764
DE - Germania 1.294
UA - Ucraina 1.288
HK - Hong Kong 1.225
TR - Turchia 898
GB - Regno Unito 865
PL - Polonia 858
FI - Finlandia 551
FR - Francia 460
BD - Bangladesh 401
RU - Federazione Russa 394
JP - Giappone 327
SE - Svezia 326
CA - Canada 317
IN - India 309
ID - Indonesia 224
MX - Messico 213
NL - Olanda 211
AR - Argentina 203
ZA - Sudafrica 147
IQ - Iraq 118
ES - Italia 103
EC - Ecuador 85
PK - Pakistan 81
BE - Belgio 65
CO - Colombia 65
UZ - Uzbekistan 59
SA - Arabia Saudita 57
VE - Venezuela 57
LT - Lituania 50
AT - Austria 43
CZ - Repubblica Ceca 40
CL - Cile 38
MY - Malesia 38
PH - Filippine 37
AU - Australia 34
EG - Egitto 34
MA - Marocco 33
PY - Paraguay 33
JO - Giordania 31
TN - Tunisia 27
AE - Emirati Arabi Uniti 26
KE - Kenya 26
IR - Iran 25
AZ - Azerbaigian 22
CH - Svizzera 22
KR - Corea 22
IL - Israele 21
UY - Uruguay 21
AL - Albania 20
DZ - Algeria 20
IE - Irlanda 20
NP - Nepal 19
CR - Costa Rica 18
JM - Giamaica 18
KZ - Kazakistan 16
PE - Perù 16
RO - Romania 16
EE - Estonia 15
ET - Etiopia 14
KG - Kirghizistan 14
LK - Sri Lanka 14
TW - Taiwan 14
BO - Bolivia 13
DO - Repubblica Dominicana 13
OM - Oman 13
TH - Thailandia 13
PS - Palestinian Territory 12
PT - Portogallo 12
BG - Bulgaria 11
RS - Serbia 11
LB - Libano 10
GE - Georgia 9
HN - Honduras 9
SN - Senegal 8
GR - Grecia 7
HR - Croazia 7
MD - Moldavia 7
NO - Norvegia 7
SK - Slovacchia (Repubblica Slovacca) 7
TT - Trinidad e Tobago 7
BH - Bahrain 6
LV - Lettonia 6
CI - Costa d'Avorio 5
DK - Danimarca 5
GT - Guatemala 5
KW - Kuwait 5
BB - Barbados 4
CY - Cipro 4
EU - Europa 4
LY - Libia 4
NI - Nicaragua 4
PA - Panama 4
AO - Angola 3
HU - Ungheria 3
Totale 58.465
Salva come PNG Salva come JPEG
Città #
Singapore 3.637
Ashburn 3.563
Fairfield 3.039
Woodbridge 2.827
San Jose 1.886
Houston 1.778
Jacksonville 1.386
Ann Arbor 1.271
Chandler 1.231
Seattle 1.209
Hong Kong 1.196
Santa Clara 1.152
Beijing 1.149
Cambridge 1.071
Wilmington 1.062
Warsaw 833
Ho Chi Minh City 580
Ferrara 563
Los Angeles 515
Dallas 501
Izmir 491
New York 460
Nanjing 391
Hanoi 386
Council Bluffs 323
Princeton 312
Tokyo 305
Lauterbourg 285
Milan 272
Boardman 256
Munich 254
San Diego 241
São Paulo 194
Helsinki 185
Shanghai 172
Jakarta 157
Orem 149
Buffalo 140
Bologna 136
Shenyang 128
Mexico City 127
Nanchang 125
London 117
Dearborn 110
Chicago 107
Rome 105
Hefei 99
Tianjin 98
Montreal 94
Da Nang 90
Johannesburg 90
Turku 89
Chennai 86
Denver 86
The Dalles 85
Frankfurt am Main 82
Brooklyn 81
Changsha 77
Hebei 70
Haiphong 69
San Francisco 69
Toronto 69
Moscow 67
Stockholm 65
Columbus 64
Jiaxing 64
Atlanta 62
Brussels 62
Dong Ket 62
Falls Church 61
Mountain View 60
Poplar 56
Bremen 55
Jinan 55
Phoenix 55
Boston 51
San Mateo 51
Rio de Janeiro 50
Norwalk 49
Zhengzhou 48
Manchester 47
Tashkent 47
Baghdad 46
Kunming 46
Mumbai 45
Auburn Hills 42
Falkenstein 42
Belo Horizonte 40
Curitiba 40
Redwood City 38
Verona 38
Ankara 37
Hải Dương 36
Naples 36
Porto Alegre 35
Amsterdam 34
Guangzhou 33
Nuremberg 33
Tappahannock 33
Quito 32
Totale 39.528
Salva come PNG Salva come JPEG
Nome #
Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice—from a human poisoning case to the preclinical evidence 566
Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in Cognitive Impairment Diseases 487
Trattato di Anatomia Umana 381
Cell cycle block by p53 acrivation reduces SARS-COV-2 release in infected alveolar basal epithelial A549-hACE2 cells 345
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 334
Trattato di Anatomia Umana 332
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 301
The synthetic cathinones MDPHP and MDPV: Comparison of the acute effects in mice, in silico ADMET profiles and clinical reports 297
Targeting mTOR in Acute Lymphoblastic Leukemia 293
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines 289
Cardiovascular disease-related miRNAs expression: Potential role as biomarkers and effects of training exercise 285
Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells 278
Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia 278
Changes of nuclear protein kinase C activity and isotype composition in PC12 cell proliferation and differentiation 275
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 275
Intranasal Administration of Recombinant TRAIL Down-Regulates CXCL-1/KC in an Ovalbumin-Induced Airway Inflammation Murine Model 275
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 272
MDM2/X inhibitors under clinical evaluation: Perspectives for the management of hematological malignancies and pediatric cancer 268
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 265
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism 261
COVID-19 and individual genetic susceptibility/receptivity: Role of ACE1/ACE2 genes, immunity, inflammation and coagulation. might the double x-chromosome in females be protective against SARS-COV-2 compared to the single x-chromosome in males? 258
Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia 257
A Brain Hidden in the Ferrara Cathedral: A Novel Interpretation of a Renaissance Masterpiece 257
Impact of physical exercise in cancer survivors during and after antineoplastic treatments 255
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells 254
An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently tat-transfected cells and required for optimal HIV-1 LTR transactivating activity 253
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia 251
Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells 250
Antiangiogenic activity of the MDM2 antagonist nutlin-3 250
Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye 250
Actively targeted nanocarriers for drug delivery to cancer cells 250
Association between thyroid hormones and TRAIL 249
HelixComplex snail mucus exhibits pro-survival, proliferative and pro-migration effects on mammalian fibroblasts 246
Association of serum tumor necrosis factor-related apoptosis inducing ligand with body fat distribution as assessed by dual X-rays absorptiometry 242
Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging 242
Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults 241
All-trans retinoic acid shows multiple effects on the survival, proliferation and differentiation of human fetal CD34+ haemopoietic progenitor cells. 240
Targeting the phosphatidylinositol 3-kinase/Akt/mechanistic target of rapamycin signaling pathway in B-lineage acute lymphoblastic leukemia: An update 238
Roles and clinical implications of microRNAs in acute lymphoblastic leukemia 237
Serum Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Levels in Older Subjects with Dementia and Mild Cognitive Impairment 236
Multiple dye-doped NIR-emitting silica nanoparticles for both flow cytometry and in vivo imaging 234
Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments 233
GM-CSF Exhibits Anti-Inflammatory Activity on Endothelial Cells Derived from Chronic Venous Disease Patients 229
Cytokine levels in the serum of healthy subjects 229
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 229
Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70 228
TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress 228
TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications 227
The circulating levels of TRAIL are extremely low after delivery but rapidly recover in both mothers and newborns 226
The MDM-2 antagonist nutlin-3 promotes the maturation of acute myeloid leukemic blasts 225
Circulating levels of frizzled-related protein (FRZB) are increased in patients with early rheumatoid arthritis and decrease in response to disease-modifying antirheumatic drugs. 225
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-hodgkin's lymphoma xenografts 225
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes 224
Association of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) with Central Adiposity and Low-Density Lipoprotein Cholesterol 224
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 224
Clinical perspectives of TRAIL: Insights into central nervous system disorders 222
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells 221
Flow cytometric quantification of HIV-1 Tat protein in tat-transfected Jurkat T cell lines 219
Accuracy of intraocular lens power calculation for cataract surgery after deep anterior lamellar keratoplasty 218
Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy 215
Applications of nanoparticles in cancer medicine and beyond: optical and multimodal in vivo imaging, tissue targeting and drug delivery 214
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 214
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets 214
TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release 213
Human Herpesvirus 7 infection induces profound cell cycle perturbations coupled to disregulation of cdc2 and cyclin B and polyploidization of CD4+ T Cells 212
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53(wild-type) JVM-2 But Not Towards p53(mutated) BJAB Leukemic Cells 212
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL) 212
Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells 212
Extracellular HIV-1 tat protein activates phosphatidylinositol 3- and Akt/PKB kinases in CD4+ T lymphoblastoid jurkat cells 211
Lovastatin dose-dependently potentiates the pro-inflammatory activity of lipopolysaccharide both in vitro and in vivo 211
Redox signaling and oxidative stress: Cross talk with TNF-related apoptosis inducing ligand activity 210
Stroma-derived factor 1α induces a selective inhibition of human erythroid development via the functional upregulation of Fas/CD95 ligand 209
HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells 208
Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity 208
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells 208
In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody. 208
Circulating TRAIL shows a significant post-partum decline associated to stressful conditions 207
MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway 205
Extracellular HIV-1 Tat protein differentially activates the JNK and ERK/MAPK pathways in CD4 T cells 205
Effects of hypoxia and bed rest on markers of cardiometabolic risk: Compensatory changes in circulating trail and glutathione redox capacity 205
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 204
Involvement of TRAIL/TRAIL-receptors in human intestinal cell differentiation 203
In vitro growth of human fetal CD34+ cells in the presence of various combinations of recombinant cytokines under serum-free culture conditions 203
HIV-1 Tat protein down-regulates CREB transcription factor expression in PC12 neuronal cells through a phosphatidylinositol 3-kinase/AKT/cyclic nucleoside phosphodiesterase pathway 202
Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells 202
HIV-1 Tat induces tyrosine phosphorylation of p125(FAK) and its association with phosphoinositide 3-kinase in PC12 cells 201
The MDM2 inhibitor Nutlin-3 attenuates streptozotocin-induced diabetes mellitus and increases serum level of IL-12p40. 201
Natural Killer Cells in SARS-CoV-2-Vaccinated Subjects with Increased Effector Cytotoxic CD56dim Cells and Memory-Like CD57+NKG2C+CD56dim Cells 200
Influence of physical exercise on microRNAs in skeletal muscle regeneration, aging and diseases 200
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 198
Exogenous human immunodeficiency virus type‐1 Tat protein selectively stimulates a phosphatidylinositol‐specific phospholipase C nuclear pathway in the Jurkat T cell line 197
Role of physical exercise in the regulation of epigenetic mechanisms in inflammation, cancer, neurodegenerative diseases, and aging process 197
SARS-CoV-2 nucleocapsid-protein and ultrastructural modifications in small bowel of a four week negative COVID-19 patient 197
HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: A potential molecular mechanism to escape TRAIL cytotoxicity 196
Multimodal near-infrared-emitting PluS Silica nanoparticles with fluorescent, photoacoustic, and photothermal capabilities 196
Heterogeneity of mesenchymal stromal cells in lymphoproliferative disorders 196
Proper design of silica nanoparticles combines high brightness, lack of cytotoxicity and efficient cell endocytosis 195
Molecular targets for selective killing of TRAIL-resistant leukemic cells. 194
Mesenchymal stem cells display hepato-protective activity in lymphoma bearing xenografts 194
Release of a specific set of proinflammatory adipokines by differentiating 3T3-L1 cells 191
Totale 23.983
Salva come PNG Salva come JPEG
Categoria #
all - tutte 250.018
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.098
Totale 253.116
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021316 0 0 0 0 0 0 0 0 0 0 0 316
2021/20223.048 109 312 243 136 158 180 158 177 119 257 363 836
2022/20233.019 334 136 119 357 462 472 103 271 387 52 186 140
2023/20241.541 179 207 73 42 106 195 61 147 42 41 64 384
2024/20257.965 257 192 604 332 995 610 356 485 1.372 775 1.125 862
2025/202622.515 2.133 961 1.984 2.733 3.033 1.508 2.515 1.271 2.081 2.527 1.237 532
Totale 59.210